Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-30

FDA Approved: OXCARBAZEPINE — Original Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approves the original application for oxcarbazepine from Advagen Pharma Ltd, granting approval for a generic version of the antiseizure medication. This app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

ORIG AP for OXCARBAZEPINE (OXCARBAZEPINE)